The FDA has granted Emergency Use Authorization (EUA) to Regeneron Pharmaceuticals for casirivimab and imdevimab, administered together, as a treatment for COVID-19. This is...
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment...
The U.S. Food and Drug Administration (FDA) has approved the first treatment for COVID-19. The drug remdesivir, now named Veklury by Gilead Sciences, received...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is going to start a clinical trial, and...
The Federal Department of Health and Human Services announced this week that the federal government has purchased more than 500,000 treatment courses of the...